|
|
 | | | |
- close
- close
- close
- close
QUOTE AND NEWS
Business Wire
May 18
Comment
The following letter was provided to shareholders by CEL-SCI Corporation (NYSE MKT: CVM) for today’s annual shareholder meeting: Dear Fellow Shareholders: Last year, 2011, was an exciting year for us because we were finally able to start our Phase
Benzinga
May 10
Comment
CEL-SCI Corporation (NYSE: CVM) announced today financial results for the fiscal quarter ended March 31, 2012.
CEL-SCI reported that net loss available to common shareholders for the quarter ended March 31, 2012 was $(10,086,959) versus...
Business Wire
May 10
Comment
CEL-SCI Corporation (NYSE AMEX: CVM) announced today financial results for the fiscal quarter ended March 31, 2012. CEL-SCI reported that net loss available to common shareholders for the quarter ended March 31, 2012 was $(10,086,959) versus
TheStreet.com
Apr 5
Comment
BOSTON (TheStreet) -- This week's Biotech Stock Mailbag is open.
Larry P. asks, "What do you think about Ampio Pharmaceuticals and its Australian approval filing for Zertane to treat premature ejaculation."
I always find it a bit bizarre...
Business Wire
Mar 6
Comment
CEL-SCI Corporation (NYSE Amex: CVM) announced today that it has fully paid off its outstanding convertible debenture. The Company had been making monthly payments of approximately $1 million per month to repay a $9 million convertible debenture
BusinessWeek
Feb 26
Comment
Units from Telemar Participacoes, the Brazilian telephone-service provider that operates the Oi brand, jumped after Brazil’s securities regulator rejected complaints against the company’s restructuring process.
Benzinga
Jan 26
Comment
CEL-SCI Corporation (NYSE: CVM) has entered into definitive agreements to sell 16,000,000 shares of its common stock at a price per share of $0.36 pursuant to a registered direct offering to an institutional investor, representing gross proceeds...
Benzinga
Jan 23
Comment
Shares of CEL-SCI Corporation (NYSE: CVM) are seeing much strength in Monday's pre-market session after the company announced on Friday some optimistic data on its Phase 3 trial.
The company sent a letter to share holders, saying, "During...
Benzinga
Jan 20
Comment
The following letter is being released by CEL-SCI Corporation (NYSE: CVM) to its shareholders:
Dear Fellow Shareholders:
With the start of the New Year, I thought it would be helpful to provide you with a review of the progress made in our...
StreetInsider.com
Dec 27
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/CEL-SCI+%28CVM%29+Expands+Multikine+Phase+III+to++Spain%2C+Czech+Republic%2C+Slovakia%2C+Croatia/7042752.html for the full story.
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
